Additionally, our current findings of CRL4 regulation on the expression of antiapoptotic protein BIRC3 in ovarian cancer support the notion that abnormal expression of CRL4 is mostly responsible for chemoresistance in ovarian cancer. Here, BIRC3 is linked to ovarian cancer.